Statement 1 Adults with, or at risk of, chronic kidney disease (CKD) have eGFRcreatinine and albumin:creatinine ratio (ACR) testing at the frequency agreed with their healthcare professional. [2011, updated 2017]
Statement 2 Adults with CKD have their blood pressure maintained within the recommended range. [2011, updated 2017]
Statement 3 Adults with CKD are offered atorvastatin 20 mg. [new 2017]
In 2017 this quality standard was updated, and statements prioritised in 2011 were updated (2011, updated 2017) or replaced (new 2017). For more information, see update information.
Statements from the 2011 quality standard for CKD that are still supported by the evidence may still be useful at a local level:
People with CKD who may benefit from specialist care are referred for specialist assessment in accordance with NICE guidance.
People with CKD have a current agreed care plan appropriate to the stage and rate of progression of CKD.
People with CKD are assessed for cardiovascular risk.
People with CKD are assessed for disease progression.
People with anaemia of CKD have access to and receive anaemia treatment in accordance with NICE guidance.
People with progressive CKD whose eGFR is less than 20 ml/min/1.73 m2, and/or who are likely to progress to established kidney failure within 12 months, receive unbiased personalised information on established kidney failure and renal replacement therapy options.
People with established renal failure have access to psychosocial support (which may include support with personal, family, financial, employment and/or social needs) appropriate to their circumstances.
The 2011 quality standard for CKD is available as a pdf.